Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Fluconazole is an effective antifungal medication with potential side effects and lacks official analytical methods for its determination.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride may help some women with hair loss, but better options exist.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.